October 5, 2017 — Infinitt North America announced it will highlight several healthcare information technology (IT) offerings in its booth at the 2017 Annual Meeting of the Radiological Society of North America (RSNA 2017), Nov. 26-Dec. 1 in Chicago.

Infinitt PACS (picture archiving and communication system) includes:

External researchers presented new clinical data supporting the use of iCAD’s Xoft Axxent Electronic Brachytherapy (eBx) System for the treatment of nonmelanoma skin cancer (NMSC) and early-stage breast cancer during the 2017 American Society for Radiation Oncology (ASTRO) meeting, Sept. 24-27 in San Diego. iCAD also hosted additional presentations and a series of peer-to-peer discussion opportunities with leading eBx experts at its booth.

MedLever demonstrated its flagship platform and applications that simplify clinical workflow, enable interoperability, and enhance clinical and scientific research at the 2017 American Society for Radiation Oncology (ASTRO) Annual Meeting, Sept. 24-27 in San Diego.

October 5, 2017 — CompleWare and Vida recently announced a joint marketing agreement promoting complementary respiratory services. Their partnership will deploy a high-end pulmonary platform and excellence in clinical trial management, with precision, ISO-certified core lab imaging. 

October 5, 2017 — To provide lifesaving surgical care for sick children in one of the most underserved countries, 13 volunteers including 10 medical personnel from Cincinnati Children’s Hospital Medical Center recently completed their second annual mission to Tanzania. Toshiba Medical, a Canon Group company, donated its Viamo portable ultrasound system during the mission at Bugando Medical Centre in Mwanza, Tanzania, serving about 13 million people in the region.

Blue Earth Diagnostics recently announced the results of a pre-planned interim analysis from an investigational clinical trial evaluating the impact of fluciclovine (18F) PET/CT imaging on clinical management of men with biochemically recurrent prostate cancer eligible for salvage therapy.

HCA Healthcare Gulf Coast Division and Solis Mammography have entered into a joint venture agreement to make breast health diagnostic services more accessible and convenient across the greater Houston region. The collaboration will result in 16 local sites by the end of 2018, including the Oct. 2 grand opening of a new dedicated breast health center at HCA-affiliated The Woman’s Hospital of Texas.

Findings from a new multicenter, international clinical trial confirm the effectiveness of high-dose brachytherapy or internal radiation therapy, for managing locally advanced cervical cancer. Tumor control was significantly better following four fractions of 7 Gray (Gy) each than following two, 9-Gy fractions of high-dose-rate (HDR) brachytherapy, but neither overall survival nor severe treatment-related side effects differed between the treatment groups.

October 4, 2017 — Kubtec announced at the annual conference of the American Association of Pathology Assistants (AAPA) that they are expanding their proprietary use of 3-D tomosynthesis by bringing it to the XPERT 80 Specimen X-ray System. Kubtec introduced 3-D imaging for clinical specimens with the Mozart System, the first specimen X-ray system to use 3-D tomosynthesis, according to the company. 
 

In the 1980s I was enthralled with hybridomas. Created by fusing human tumor cells with cells from mouse spleens that had been sensitized to the patient’s own cancer, they were supposed to pump out the magic bullets that finally would take cancer down. At the time, I believed it.

Thirty years later, the jury is still out.

Immune technology is taking some impressive steps. But it has not lived up to early expectations.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now